← Back
$APRE All transactions

Aprea Therapeutics, Inc.

A

$ Value

$0

Shares

80,700

Price

$0

Filed

Mar 16

Insider

Name

Gilad Oren

Title

President/CEO

CIK

0001929300

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

80,700

Footnotes

These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions. | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. | Twenty-five percent of these options vest on March 12, 2027, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Filing Info

Accession No.

0001104659-26-028656

Form Type

4

Issuer CIK

0001781983

Gilad Oren's History

Date Ticker Type Value
2026-03-12 APRE A $0
2026-03-12 APRE A $0
2026-01-30 APRE $25K
2026-01-30 APRE
2025-12-10 APRE $25K
2025-12-10 APRE

Other Insiders at APRE (90d)

Insider Bought Sold Last
Peters Richard $100K 2026-03-31
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
$30K 2026-03-31
Gilad Oren
President/CEO
$25K 2026-03-12